Skip to main content

Table 1 TH levels in rat serum before surgery and at the 3- and 14-d endpoints.

From: Early and Short-term Triiodothyronine Supplementation Prevents Adverse Postischemic Cardiac Remodeling: Role of Transforming Growth Factor-β1 and Antifibrotic miRNA Signaling

 

FT3 (pg/mL)

FT4 (pg/mL)

 

Basal

3 d

14 d

Basal

3 d

14 d

Sham

3.0 ± 0.1

3.0 ± 0.07

3.3 ± 0.06

11.1 ± 0.6

13.2 ± 0.5

12.2 ± 0.9

I/R-L

2.9 ± 0.2

2.3 ± 0.05a,b

3.0 ± 0.2c

10.9 ± 0.5

11.8 ± 0.5

10.2 ± 0.8

I/R-L+T3

2.7 ± 0.2

5.1 ± 0.2a,b

3.0 ± 0.1c

11.4 ± 0.8

3.3 ± 0.8a,b

11.6 ± 0.7c

  1. Data are mean ± SEM; n ≥ 12 in each group for 3 d post-I/R and n ≥ 6 in each group for 14 d post-I/R.
  2. ap ≤ 0.0004 versus respective basal levels;
  3. bp ≤ 0.002 versus sham basal levels;
  4. cp ≤ 0.001 versus respective 3-d levels.